What is Pulmonary Associates?
Pulmonary Associates operates as a specialized medical provider focused on the comprehensive management and treatment of complex pulmonary conditions. Their clinical portfolio encompasses critical diagnostic and therapeutic services, including bronchoscopy, pulmonary function testing, and home sleep studies. By addressing a broad spectrum of respiratory ailments—ranging from chronic asthma to lung cancer—the clinic serves as a vital node in the regional healthcare infrastructure. Their commitment to accessibility, evidenced by the acceptance of both public and private insurance, underscores a patient-centric model designed to serve a diverse demographic across all age groups.
How much funding has Pulmonary Associates raised?
Pulmonary Associates has raised a total of $738K across 2 funding rounds:
Debt
$350K
Debt
$388K
Debt (2020): $350K with participation from PPP
Debt (2021): $388K led by PPP
Key Investors in Pulmonary Associates
PPP
Public-Private Partnership
What's next for Pulmonary Associates?
With this recent strategic investment, Pulmonary Associates is poised to scale its diagnostic capabilities and refine its long-term patient care protocols. The infusion of capital provides the necessary liquidity to upgrade medical equipment and potentially expand the clinic's footprint in the respiratory health sector. As the organization transitions into this next phase of growth, the focus will likely remain on optimizing clinical outcomes and integrating advanced diagnostic technologies to maintain its market position as a leader in pulmonary disease management.
See full Pulmonary Associates company page
